Singapore · Biotechnology startup
Singapore · RVAC Medicines Pte. Ltd.
RVAC is a Singapore-based biotechnology company that develops and commercializes mRNA vaccines for the treatment of infectious and other diseases.
Funding reportedLast round: Series B
Follow RVAC Medicines Pte. Ltd. and see its new rounds in your feed.Start following
What company datasets say RVAC Medicines Pte. Ltd. raised
Funding, as reported
Reported in all140Min the source's currency
Rounds1
Last roundSeries B
Last round size140M
Last round dateApr 2022
Investors listed4
The company, in detail
What they build
Built with from their website
CloudFlare CDN
- Sector
- Biotechnology
- Region
- Singapore
- Revenue
- 1.5M a year, as listed
- Full record
- Every detail in the company directory
Biotechnology in Singapore
Startups like it
Is this your company?
Add your raise, your deck and your story, and put RVAC Medicines Pte. Ltd. in front of investors. Or tell us what we have wrong.